Skip to main content
. 2019 Jan 23;9:3325. doi: 10.3389/fmicb.2018.03325

FIGURE 5.

FIGURE 5

Asprellcosides B represses influenza A virus replication at the early stage of its lifecycle. Cells were inoculated with 50TCID50: 0.1 mL of the influenza virus A/FM/1/47(H1N1) in a time-of-addition assay. 18.8–150 μM of Asprellcosides B was added at the designated times and was removed after each incubation period. The cells were then incubated with fresh media until 48 h post infection. The virus replication was determined through Neuraminidase assay. n = 3, each concentration performed in triplicate.